checkpoint inhibitors
1 product
9 abstracts
Abstract
First-line treatment of fecal microbiota transplantation for immune-mediated colitis.Org: University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center,
Abstract
Correlation of immune phenotypes derived from H&E-stained whole slide images with prognosis and response to checkpoint inhibitors in NSCLC.Org: PathAI, Incendia Therapeutics, Explicyte Immuno-Oncology, Institut Bergonié, Early Phase Trials Unit, Institut Bergonié and University of Bordeaux, Bordeaux, France,
Abstract
Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C.Org: CEPCM AP-HM,
Abstract
First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting.Org: Ipsen Biopharmaceuticals,
Abstract
RET testing and treatment patterns among aNSCLC patients in US clinical practice.Org: Genentech, University of Washington and Fred Hutchinson Cancer Research Centre, Mayo Clinic,
Abstract
Are we ready to mitigate time toxicity of cancer care? Oncologists’ perceptions on digital interventions to fast-track cancer care.Org: Memorial Sloan Kettering Cancer Center, Penn Abramson Cancer Center, Abramson Cancer Center, University of Pennsylvania, Department of Family Medicine & Community Health, PSOM, University of Pennsylvania Health System,
Abstract
Impact of immunotherapy on intracranial progression-free survival in patients with advanced lung cancer and melanoma with brain metastasis: A single-center retrospective study and comparison of the pre- and post-immunotherapy era.Org: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, East Tennessee State University Quillen College of Medicine, Department of Epidemiology and Data Science, East Tennessee State University College of Public Health, Ballad Health Cancer Care,
Abstract
Survival in patients with unresectable melanoma: To infinity and beyond?Org: University Medical Center of Utrecht, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands, VU University Medical Center, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute,
Product
checkpoint inhibitorsAbstract
Assessment of the utilization of immunotherapy in Sub-Saharan Africa.Org: Johns Hopkins University School of Medicine, BIO Ventures for Global Health (BVGH), Seattle, WA, Inkosi Albert Luthuli Central Hospital, Durban-South Africa, University of Nigeria Teaching Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine,